News About: Pharm. Affairs
11 Korean-developed medicines break the U.S. and EU wall of approval
11 medicines which were developed by Korean pharmaceutical companies after 2013 have reportedly been well sold as breaking the wall of approval of the U.S. and European Union.
According to the Ministry of Health and ...
Medicine trade balance was USD 354.5 million this January
The medicine trade balance reportedly recorded USD 354.5 million deficits this January.
According to the 2018 January Import and Export Status published by the Korea Customs Service, Korea exported USD 252.9 million ...
Pharmacies, “We are more worried about loss of employees than personnel expenses”
The pharmacy society seems settled now as experiencing a chaos from the personnel expense issue, caused by the increase of the minimum salary to KRW 7,530, before.
According to the society, pharmacy owners have repor...
Well-developed incrementally modified drugs over new drugs
Incrementally modified drugs with upgraded features from existing approved products have reportedly played key roles for Korean pharmaceutical companies over new drugs which consumed a ton of funds.
According to the ...
8 of 10 medicines approved February were generics
8 of 10 medicines approved last month were reportedly generics.
According to the Ministry of Food and Drug Safety Online Drug Library, there were 36 OTC drugs, 130 ETC drugs approved, totaling 166 products.
The rati...
1 of 3 medicines approved as incrementally modified drug were ‘antihypertensive’
It was analyzed total 93 products have been approved as incrementally modified drug since the adoption of the incrementally modified drug system in 2009, and 1 of the 3 incrementally modified drugs were antihypertensi...
Products like ‘Repatha Inj’ & ‘Soolantra Cream 1%’ enter Asan Medical Center
Amgen’s ‘Repatha Inj’ and Galderma’s ‘Soolantra Cream 1%’ entered Asan Medical Center.
At the 142nd Drug Committee, Asan Medical Center approved introduction of ‘Repatha Inj,’ the Amgen Korea’s PCSK9-inhibiting chole...
161 products including ‘Arnuity’ & ‘Abcertin’ newly registered for NHIS
161 products including ‘Arnuity,’ an asthma therapy, and ‘Abcertin,’ a Gaucher disease treatment, were newly registered in the National Health Insurance Service(NHIS).
The Ministry of Health and Welfare(MOHW) revised...
Herceptin become most prescribed biologic with KRW 100 billion
‘Herceptin,’ a breast cancer therapy, has become the only biologic with more than KRW 100 billion prescriptions a year.
CoreZetta(CEO Hong-Ki Lee), a health care big data company, analyzed data about 22 biologics tur...
Rapid increase of bioequivalently proven medicines, what is the reason?
The number of medicines bioequivalently proven this year was 157 products, reportedly increased by 58%.
The phenomenon was caused by the fact the Korean pharmaceutical companies have been active in developing generic...
